查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
到 2030 年北美微載體市場預測 - 區域分析 - 按產品、設備、應用和最終用戶
市場調查報告書
商品編碼
1494453

到 2030 年北美微載體市場預測 - 區域分析 - 按產品、設備、應用和最終用戶

North America Microcarriers Market Forecast to 2030 - Regional Analysis - by Product, Equipment, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 89 Pages | 訂單完成後即時交付

價格

北美微載體市場預計將從2022年的7.3667億美元成長到2030年的19.3356億美元。

細胞和基因治療製造服務的自動化推動了北美微載體市場

在細胞和基因治療製造中納入自動化將降低污染風險、提高一致性並降低生產成本。 Lonza Cocoon 和 Miltenyi 的 CliniMACS Prodigy 系統是市場上現有的一些設備，這些設備旨在實現單一系統內 CAR-T 流程的大多數順序單元操作的自動化。對細胞和基因療法不斷成長的需求已將全球範圍內的生產從小批量製程轉向大批量製程。細胞和基因療法從學術和臨床環境到大規模生產和商業化的進展進一步推動了商業製造對自動化的需求。 2020 年 7 月，Thermo Fisher Scientific Inc. 和 Lyell Nutrition 合作開發流程，為癌症患者設計有效的細胞療法。根據這項合作關係，兩家公司的目標是提高 T 細胞的能力，並支持開發符合現行良好生產規範 (cGMP) 的綜合平台（系統和軟體）以及試劑、耗材和儀器。此外，美國政府援助的組織正在細胞療法的製造中採用自動化，以提高該國的國家生產能力。因此，自動化正在成為微載體市場的新趨勢。

北美微載體市場概況

北美微載體市場分為美國、加拿大和墨西哥。美國在該地區市場佔據主導地位。北美微載體市場的成長歸因於生物技術和生物製藥公司推出的產品數量不斷增加、主要市場參與者的存在以及各個學術和研究機構的廣泛研發。慢性病盛行率的上升是推動美國微載體市場成長的主要因素。根據美國疾病管制與預防中心 (CDC) 的數據，十分之六的美國人患有至少一種慢性疾病，例如心臟病、中風、癌症或糖尿病。這些疾病是美國死亡和殘疾的重要原因，而且還導致巨大的醫療費用。細胞和基因療法（CGT）領域取得了廣泛的臨床進展，因此這些療法的應用範圍在過去5年中不斷擴大。在 2016 年至 2021 年的分析期間，隨著 12 種新療法的批准和超過 2,900 項臨床試驗的啟動，CGT 創新得到了廣泛的投資。基因編輯技術的進步，以及評估此技術治療效果的臨床試驗，是有利於美國微載體市場的其他因素。例如，Poseida Therapeutics, Inc. 的P-CD19CD20-ALLO1 的研究性新藥(IND) 申請獲得美國食品和藥物管理局(FDA) 批准，這是該公司首款同時靶向CD19 和CD19 的同種異體雙CAR-T 細胞候選產品。 2023 年 4 月，新型同種異體 CAR T 細胞療法在轉移性透明細胞腎細胞癌患者中取得了成果。因此，增加臨床試驗的參與和投資可以加速新療法的採用和可用性。德州大學MD 安德森癌症中心的研究人員領導了I 期試驗，並在美國癌症研究協會(AACR) 2023 年年會上進行了報告。 , Inc. 宣布對支持 Poseida 重新定義癌細胞療法的承諾。安斯泰來投資 5000 萬美元獲得 Poseida 一項臨床階段計畫的許可，該計畫專注於 P-MUC1C-ALLO1，這是一種用於多種實體瘤適應症的同種異體 CAR T 細胞療法。因此，隨著慢性病病例數量的增加以及不同細胞和基因療法的批准，美國對微載體的需求正在增加。

北美微載體市場營收及 2030 年預測（百萬美元）

北美微載體市場細分

北美微載體市場分為產品、設備、應用、最終用戶和國家。

根據產品，北美微載體市場分為微載體珠和培養基和試劑。 2022 年，微載體珠細分市場在北美微載體市場中佔有更大佔有率。

在設備方面，北美微載體市場分為生物反應器、培養皿等。 2022 年，生物反應器領域佔據北美微載體市場的最大佔有率。

根據應用，北美微載體市場分為生物製藥生產、細胞和基因治療、組織工程和再生醫學等。 2022年，生物製藥生產領域在北美微載體市場中佔據最大佔有率。

根據最終用戶，北美微載體市場分為製藥和生物技術公司、合約研究組織和合約製造組織以及學術和研究機構。 2022 年，製藥和生物技術公司領域佔據北美微載體市場的最大佔有率。

根據國家/地區，北美微載體市場分為美國、加拿大和墨西哥。 2022 年，美國主導北美微載體市場。

Teijin Ltd、Bio-Rad Laboratories Inc、Sartorius AG、Danaher Corp、Corning Inc、Eppendorf SE、Asahi Kasei Corp 和 Polysciences Inc 是北美微載體市場上的一些領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美微載體市場 - 主要產業動態

  • 主要市場促進因素：
    • 隨著癌症和傳染病發病率的上升，對細胞療法的需求
    • 外包細胞和基因治療製造越來越受歡迎
    • 再生醫學的採用激增
  • 市場限制
    • 生物製劑和細胞療法的高成本
  • 市場機會
    • 微載體製造商的策略性舉措和創新產品
  • 未來的趨勢
    • 細胞和基因治療製造服務的自動化
  • 影響分析

第 5 章：微載體市場 - 北美市場分析

  • 微載體市場收入，2022 - 2030

第 6 章：北美微載體市場 - 收入和 2030 年預測 - 按產品

  • 概述
  • 2022 年和 2030 年按產品分類的微載體市場收入佔有率 (%)
  • 微載體珠
  • 介質和試劑

第 7 章：北美微載體市場 - 收入和 2030 年預測 - 按設備

  • 概述
  • 2022 年及 2030 年按設備分類的微載體市場收入佔有率 (%)
  • 生物反應器
  • 培養容器
  • 其他

第 8 章：北美微載體市場 - 收入和 2030 年預測 - 按應用

  • 概述
  • 2022 年和 2030 年按應用分類的微載體市場收入佔有率 (%)
  • 生物製藥生產
  • 細胞和基因治療
  • 組織工程與再生醫學
  • 其他

第 9 章：北美微載體市場收入和 2030 年預測 - 最終用戶

  • 概述
  • 北美微載體最終用戶市場佔有率 - 2022 年和 2030 年 (%)
  • 製藥和生物技術公司
    • 概述
    • 製藥和生物技術公司：微載體市場 - 收入和 2030 年預測
  • 合約研究組織和合約製造組織
    • 概述
    • 合約研究組織和合約製造組織：微載體市場 - 收入和 2028 年預測
  • 學術及研究機構
    • 概述
    • 學術和研究機構：微載體市場 - 收入和 2028 年預測

第 10 章：北美微載體市場收入和 2030 年預測 - 國家分析

    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥

第 11 章：微載體市場-產業格局

  • 概述
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 12 章：公司簡介

  • Teijin Ltd
  • Bio-Rad Laboratories Inc
  • Sartorius AG
  • Danaher Corp
  • Corning Inc
  • Eppendorf SE
  • Asahi Kasei Corp
  • Polysciences Inc

第 13 章：附錄

Product Code: BMIRE00029976

The North America microcarriers market is expected to grow from US$ 736.67 million in 2022 to US$ 1,933.56 million by 2030. It is estimated to record a CAGR of 12.8% from 2022 to 2030.

Automation of Cell and Gene Therapy Manufacturing Services Fuels North America Microcarriers Market

Incorporating automation in cell and gene therapy manufacturing would lead to a reduced risk of contamination, improved consistency, and decreased cost of production. Lonza Cocoon and the CliniMACS Prodigy system from Miltenyi are a few of the devices available in the market that have been designed to enable the automation of most sequential unit operations for a CAR-T process within a single system. The rising demand for cell and gene therapies has shifted production from a small-volume process to a large-volume process worldwide. The progress of cell and gene therapy from an academic and clinical setting to mass production and commercialization further propels the demand for automation in commercial manufacturing. In July 2020, Thermo Fisher Scientific Inc. and Lyell Immunopharma partnered to develop processes to design effective cell therapies for cancer patients. Under this partnership, the companies aim to improve the capability of T-cells and support the development of an integrated current good manufacturing practice (cGMP) compliant platform (system and software), along with reagents, consumables, and instruments. Further, the US government-aided organizations are adopting automation in the manufacturing of cell therapies to increase the national production capabilities of the country. Thus, automation is emerging as a new trend in the microcarriers market.

North America Microcarriers Market Overview

The North America microcarriers market is segmented into the US, Canada, and Mexico. The US dominates the market in this region. The growth of the microcarriers market in North America is attributed to the increasing number of product launches by biotechnology and biopharmaceutical companies, the presence of key market players, and extensive R&D by various academic and research institutes. The rising prevalence of chronic diseases is a leading factor propelling the growth of the microcarrier market in the US. According to the Centers for Disease Control and Prevention (CDC), 6 in 10 Americans live with at least 1 chronic disease, such as heart disease and stroke, cancer, or diabetes. These diseases are the significant causes of mortality and disability in the US, and they also lead to significant costs of healthcare. There have been extensive clinical developments in the field of cell and gene therapies (CGT), owing to which the application range of these therapies has expanded in the past 5 years. With the approval of 12 new therapies and the commencement of over 2,900 clinical trials during the analysis period of 2016-2021, there have been extensive investments in CGT innovations. Technological advancements in gene editing, followed by clinical trials to evaluate the therapeutic effectiveness of the technique, are the other factors that have benefitted the microcarriers market in the US. For example, Poseida Therapeutics, Inc. received the US Food and Drug Administration (FDA) approval for its Investigational New Drug (IND) application for P-CD19CD20-ALLO1-the company's first allogeneic dual CAR-T cell product candidate targeting both CD19 and CD20 antigens for the treatment of relapsed or refractory B-cell malignancies-being developed in partnership with Roche. In April 2023, Novel allogeneic CAR T-cell therapy delivered results in patients with metastatic clear cell renal cell carcinoma. Thus, increased participation and investments in clinical trials can accelerate the adoption and availability of new therapies. Researchers at the University of Texas MD Anderson Cancer Center led the Phase I trial and presented at the American Association for Cancer Research (AACR) Annual Meeting 2023. In August 2023, Astellas Pharma Inc. and Poseida Therapeutics, Inc. announced a strategic investment to support the advancement of Poseida's commitment to redefining cancer cell therapy. Astellas invested US$ 50 million to license one of Poseida's clinical-stage programs focusing on P-MUC1C-ALLO1, an allogeneic CAR T-cell therapy for multiple solid tumor indications. Thus, the demand for microcarriers is on the rise in the US with the increasing number of chronic disease cases and approval of different cell and gene therapies.

North America Microcarriers Market Revenue and Forecast to 2030 (US$ Million)

North America Microcarriers Market Segmentation

The North America microcarriers market is segmented into product, equipment, application, end user, and country.

Based on product, the North America microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held a larger share of the North America microcarriers market in 2022.

In terms of equipment, the North America microcarriers market is segmented into bioreactors, culture vessels, and others. The bioreactors segment held the largest share of the North America microcarriers market in 2022.

Based on application, the North America microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production segment held the largest share of the North America microcarriers market in 2022. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.

Based on end user, the North America microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held the largest share of the North America microcarriers market in 2022.

Based on country, the North America microcarriers market is segmented into the US, Canada, and Mexico. The US dominated the North America microcarriers market in 2022.

Teijin Ltd, Bio-Rad Laboratories Inc, Sartorius AG, Danaher Corp, Corning Inc, Eppendorf SE, Asahi Kasei Corp, and Polysciences Inc are some of the leading companies operating in the North America microcarriers market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Microcarriers Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases
    • 4.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
    • 4.1.3 Surge in Adoption of Regenerative Medicine
  • 4.2 Market Restraints
    • 4.2.1 High Cost of Biologics and Cell-based Therapies
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives and Innovative Products by Microcarrier Manufacturers
  • 4.4 Future Trends
    • 4.4.1 Automation of Cell and Gene Therapy Manufacturing Services
  • 4.5 Impact Analysis

5. Microcarriers Market - North America Market Analysis

  • 5.1 Microcarriers Market Revenue (US$ Mn), 2022 - 2030

6. North America Microcarriers Market - Revenue and Forecast to 2030 - by Product

  • 6.1 Overview
  • 6.2 Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • 6.3 Microcarrier Beads
    • 6.3.1 Overview
    • 6.3.2 Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Media and Reagents
    • 6.4.1 Overview
    • 6.4.2 Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Microcarriers Market - Revenue and Forecast to 2030 - by Equipment

  • 7.1 Overview
  • 7.2 Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • 7.3 Bioreactors
    • 7.3.1 Overview
    • 7.3.2 Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Culture Vessels
    • 7.4.1 Overview
    • 7.4.2 Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Microcarriers Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Biopharmaceutical Production
    • 8.3.1 Overview
    • 8.3.2 Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.3 Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.4 Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Cell and Gene Therapy
    • 8.4.1 Overview
    • 8.4.2 Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Tissue Engineering and Regenerative Medicine
    • 8.5.1 Overview
    • 8.5.2 Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Microcarriers Market Revenue and Forecasts To 2030 - End User

  • 9.1 Overview
  • 9.2 North America Microcarriers Market Share by End User - 2022 & 2030 (%)
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Overview
    • 9.3.2 Pharmaceutical and Biotechnology Companies: Microcarriers Market- Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Contract Research Organizations and Contract Manufacturing Organizations
    • 9.4.1 Overview
    • 9.4.2 Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)

10. North America Microcarriers Market Revenue and Forecasts to 2030 - Country Analysis

  • 10.1 North America Microcarriers Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 North America: Microcarriers Market, by Country
      • 10.1.2.1 US
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 US: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.1.3 US: Microcarriers Market, by Product
        • 10.1.2.1.4 US: Microcarriers Market, by Equipment
        • 10.1.2.1.5 US: Microcarriers Market, by Application
        • 10.1.2.1.5.1 US: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.1.6 US: Microcarriers Market, by End User
      • 10.1.2.2 Canada
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Canada: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.3 Canada: Microcarriers Market, by Product
        • 10.1.2.2.4 Canada: Microcarriers Market, by Equipment
        • 10.1.2.2.5 Canada: Microcarriers Market, by Application
        • 10.1.2.2.5.1 Canada: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.2.6 Canada: Microcarriers Market, by End User
      • 10.1.2.3 Mexico
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 Mexico: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.3 Mexico: Microcarriers Market, by Product
        • 10.1.2.3.4 Mexico: Microcarriers Market, by Equipment
        • 10.1.2.3.5 Mexico: Microcarriers Market, by Application
        • 10.1.2.3.5.1 Mexico: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.3.6 Mexico: Microcarriers Market, by End User

11. Microcarriers Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Growth Strategies
    • 11.2.1 Overview
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Teijin Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Bio-Rad Laboratories Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Sartorius AG
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Danaher Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Corning Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Eppendorf SE
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Asahi Kasei Corp
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Polysciences Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Microcarriers Market Segmentation
  • Table 2. US Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 3. US Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 4. US Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 5. US Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 6. US: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 7. Canada Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 8. Canada Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 9. Canada Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 10. Canada Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 11. Canada: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 12. Mexico Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 13. Mexico Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 14. Mexico Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 15. Mexico Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 16. Mexico: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 17. Recent Organic Growth Strategies in Microcarriers Market
  • Table 18. Recent Inorganic Growth Strategies in the Microcarriers Market
  • Table 19. Glossary of Terms

List Of Figures

  • Figure 1. Microcarriers Market Segmentation, By Country
  • Figure 2. Key Insights
  • Figure 3. Microcarriers Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints for Microcarriers Market
  • Figure 5. Microcarriers Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 7. Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • Figure 10. Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 14. Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. North America Microcarriers Market Share by End User - 2022 & 2030 (%)
  • Figure 21. Pharmaceutical and Biotechnology Companies: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 22. Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 23. Academic and Research Institutes: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 24. Microcarriers Market, 2022 (US$Mn)
  • Figure 25. North America: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 26. US: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Canada: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Mexico: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)